Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Sosland Morton I.
 2. Date of Event Requiring Statement (Month/Day/Year)
08/29/2013		 3. Issuer Name and Ticker or Trading Symbol
Intra-Cellular Therapies, Inc. [N/A]
(Last)
(First)
(Middle)
4800 MAIN STREET, SUITE 100		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

KANSAS CITY, MO 64112		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 707,287
I
David N. Sosland Trust A (1)
Common Stock 1,948,554
I
Sosland Family Trust B Partnership (2)
Common Stock 732,548
I
The Sosland Foundation (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Sosland Morton I.
4800 MAIN STREET
SUITE 100
KANSAS CITY, MO 64112		     X    

Signatures

/s/ Morton I. Sosland 09/09/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reporting person is the Trustee of the David N. Sosland Trust A and the reporting person disclaims beneficial ownership of these securities except to the extent of his one-third pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
(2) The reporting person is the Managing Partner of the Sosland Family Trust B Partnership and the reporting person disclaims beneficial ownership of these securities except to the extent of his one-third pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
(3) The reporting person is the Vice Chairman of The Sosland Foundation, a charitable foundation, and the reporting person disclaims beneficial ownership of all of these securities, and the inclusion of these shares in this report shall not be an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.